- Home
- QURE vs PRA Comparison
QURE vs PRA Comparison
Compare QURE & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | PRA |
|---|---|---|
| Founded | 1998 | 1976 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2013 | 2000 |
Fundamental Metrics
Financial Performance| Metric | QURE | PRA |
|---|---|---|
| Price | $27.85 | $24.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | ★ $45.00 | $25.00 |
| AVG Volume (30 Days) | ★ 1.9M | 923.3K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $13,107,000.00 | ★ $1,098,028,000.00 |
| Revenue This Year | $126.12 | N/A |
| Revenue Next Year | $200.43 | N/A |
| P/E Ratio | ★ N/A | $150.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $22.79 |
| 52 Week High | $71.50 | $24.85 |
Technical Indicators
Market Signals| Indicator | QURE | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 30.34 |
| Support Level | $20.20 | $23.88 |
| Resistance Level | $29.03 | $24.16 |
| Average True Range (ATR) | 1.74 | 0.17 |
| MACD | -0.17 | -0.07 |
| Stochastic Oscillator | 75.56 | 25.00 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.